Neurodegenerative diseases

We synthesize, design, and test oliopyridal ligands for anti-aggregation of α-synuclein, Aβ, tau, and HTT proteins to identify, characterize, and refine potent potential therapeutics for Parkinson's Disease (PD), Huntingtin's Disease (HD), Alzheimer's Disease (AD), and Amyolateral schlerosis (ALS).


All members of our lab contribute to this research, in the forms of organic synthesis and work with αS and Aβ proteins.

We have presented on this topic at the Proteinopathy Symposium Winter 2023, ACS Spring 2024, and have plans to present on it at ACS Fall 2024.

Please see the publications page for papers published by our group on the topic.